Extension Study to Evaluate the Safety and Tolerability of NBI-921352 When Used With Anti-seizure Medications in Adults With Focal Onset Seizures
Clinical trial NCT05493293 · TERMINATED
Trial details
- NCT number
- NCT05493293
- Sponsor
- Neurocrine Biosciences
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-09
- Primary completion
- 2024-03-11
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.